Glycopyrrolate 1ml Injection
Product Images NDC 70700-264

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate 1ml (NDC 70700-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate Structural Formula (Glyco Injection 1)

Chemical structure of glycopyrrolate showing its molecular configuration including a quaternary ammonium group, ester linkage, and a bromide ion as part of the bromide salt form.*

FDA Label Image

1ml-carton (Proposed 1ml Carton)

Carton label for Glycopyrrolate Injection, USP 0.2 mg/mL, an injection for intramuscular or intravenous use. The label indicates it contains benzyl alcohol and is not for use in newborns. It is distributed by Xiromed LLC and has NDC 70700-264-22. The package contains 1 x 1 mL single-dose vial.*

FDA Label Image

1ml-vial (Proposed 1ml Vial)

GLYCOPYRROLATE 0.2 mg/mL Injection, USP in a 1 mL single-dose vial. The label shows the product name, strength, dosage form, and administration routes (intramuscular and intravenous). It contains benzyl alcohol and is distributed by Xiromed LLC, made in Spain.*

FDA Label Image

Company Logo (Xiromed)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.